154 related articles for article (PubMed ID: 31546234)
1. PRL-3 exerts oncogenic functions in myeloid leukemia cells via aberrant dephosphorylation of stathmin and activation of STAT3 signaling.
Xu J; Wu W; Tang Y; Lin Y; Xue Y; Hu J; Lin D
Aging (Albany NY); 2019 Sep; 11(18):7817-7829. PubMed ID: 31546234
[TBL] [Abstract][Full Text] [Related]
2. Stathmin, a new target of PRL-3 identified by proteomic methods, plays a key role in progression and metastasis of colorectal cancer.
Zheng P; Liu YX; Chen L; Liu XH; Xiao ZQ; Zhao L; Li GQ; Zhou J; Ding YQ; Li JM
J Proteome Res; 2010 Oct; 9(10):4897-905. PubMed ID: 20806969
[TBL] [Abstract][Full Text] [Related]
3. Phosphatase of regenerating liver-3 is regulated by signal transducer and activator of transcription 3 in acute myeloid leukemia.
Zhou J; Chong PS; Lu X; Cheong LL; Bi C; Liu SC; Zhou Y; Tan TZ; Yang H; Chung TH; Zeng Q; Chng WJ
Exp Hematol; 2014 Dec; 42(12):1041-52.e1-2. PubMed ID: 25139404
[TBL] [Abstract][Full Text] [Related]
4. The phosphatase of regenerating liver-3 (PRL-3) is important for IL-6-mediated survival of myeloma cells.
Slørdahl TS; Abdollahi P; Vandsemb EN; Rampa C; Misund K; Baranowska KA; Westhrin M; Waage A; Rø TB; Børset M
Oncotarget; 2016 May; 7(19):27295-306. PubMed ID: 27036022
[TBL] [Abstract][Full Text] [Related]
5. IL6 Promotes a STAT3-PRL3 Feedforward Loop via SHP2 Repression in Multiple Myeloma.
Chong PSY; Zhou J; Lim JSL; Hee YT; Chooi JY; Chung TH; Tan ZT; Zeng Q; Waller DD; Sebag M; Chng WJ
Cancer Res; 2019 Sep; 79(18):4679-4688. PubMed ID: 31337650
[TBL] [Abstract][Full Text] [Related]
6. LEO1 is regulated by PRL-3 and mediates its oncogenic properties in acute myelogenous leukemia.
Chong PS; Zhou J; Cheong LL; Liu SC; Qian J; Guo T; Sze SK; Zeng Q; Chng WJ
Cancer Res; 2014 Jun; 74(11):3043-53. PubMed ID: 24686170
[TBL] [Abstract][Full Text] [Related]
7. Antibody Array Revealed PRL-3 Affects Protein Phosphorylation and Cytokine Secretion.
Yang Y; Lian S; Meng L; Qu L; Shou C
PLoS One; 2017; 12(1):e0169665. PubMed ID: 28068414
[TBL] [Abstract][Full Text] [Related]
8. Phosphatase of regenerating liver-3 promotes migration and invasion by upregulating matrix metalloproteinases-7 in human colorectal cancer cells.
Lee SK; Han YM; Yun J; Lee CW; Shin DS; Ha YR; Kim J; Koh JS; Hong SH; Han DC; Kwon BM
Int J Cancer; 2012 Aug; 131(3):E190-203. PubMed ID: 22131018
[TBL] [Abstract][Full Text] [Related]
9. miR-21, miR-17 and miR-19a induced by phosphatase of regenerating liver-3 promote the proliferation and metastasis of colon cancer.
Zhang J; Xiao Z; Lai D; Sun J; He C; Chu Z; Ye H; Chen S; Wang J
Br J Cancer; 2012 Jul; 107(2):352-9. PubMed ID: 22677902
[TBL] [Abstract][Full Text] [Related]
10. Proteomic analysis identifies translationally controlled tumor protein as a mediator of phosphatase of regenerating liver-3-promoted proliferation, migration and invasion in human colon cancer cells.
Chu ZH; Liu L; Zheng CX; Lai W; Li SF; Wu H; Zeng YJ; Zhao HY; Guan YF
Chin Med J (Engl); 2011 Nov; 124(22):3778-85. PubMed ID: 22340241
[TBL] [Abstract][Full Text] [Related]
11. Stathmin gene silencing suppresses proliferation, migration and invasion of gastric cancer cells via AKT/sCLU and STAT3 signaling.
Shu F; Zou X; Tuo H; She S; Huang J; Ren H; Hu H; Peng S; Wang J; Yang Y
Int J Oncol; 2019 Mar; 54(3):1086-1098. PubMed ID: 30628664
[TBL] [Abstract][Full Text] [Related]
12. PRL-3 Promotes Ubiquitination and Degradation of AURKA and Colorectal Cancer Progression via Dephosphorylation of FZR1.
Zhang C; Qu L; Lian S; Meng L; Min L; Liu J; Song Q; Shen L; Shou C
Cancer Res; 2019 Mar; 79(5):928-940. PubMed ID: 30498084
[TBL] [Abstract][Full Text] [Related]
13. ANKHD1 silencing inhibits Stathmin 1 activity, cell proliferation and migration of leukemia cells.
Machado-Neto JA; Lazarini M; Favaro P; de Melo Campos P; Scopim-Ribeiro R; Franchi Junior GC; Nowill AE; Lima PR; Costa FF; Benichou S; Olalla Saad ST; Traina F
Biochim Biophys Acta; 2015 Mar; 1853(3):583-93. PubMed ID: 25523139
[TBL] [Abstract][Full Text] [Related]
14. Small interfering RNA-mediated knockdown of PRL phosphatases results in altered Akt phosphorylation and reduced clonogenicity of pancreatic cancer cells.
Stephens B; Han H; Hostetter G; Demeure MJ; Von Hoff DD
Mol Cancer Ther; 2008 Jan; 7(1):202-10. PubMed ID: 18187808
[TBL] [Abstract][Full Text] [Related]
15. Vinblastine differs from Taxol as it inhibits the malignant phenotypes of NSCLC cells by increasing the phosphorylation of Op18/stathmin.
Shen F; Long D; Yu T; Chen X; Liao Y; Wu Y; Lin X
Oncol Rep; 2017 Apr; 37(4):2481-2489. PubMed ID: 28259950
[TBL] [Abstract][Full Text] [Related]
16. LIN28B Activation by PRL-3 Promotes Leukemogenesis and a Stem Cell-like Transcriptional Program in AML.
Zhou J; Chan ZL; Bi C; Lu X; Chong PS; Chooi JY; Cheong LL; Liu SC; Ching YQ; Zhou Y; Osato M; Tan TZ; Ng CH; Ng SB; Wang S; Zeng Q; Chng WJ
Mol Cancer Res; 2017 Mar; 15(3):294-303. PubMed ID: 28011885
[TBL] [Abstract][Full Text] [Related]
17. Honokiol Inhibits Constitutive and Inducible STAT3 Signaling via PU.1-Induced SHP1 Expression in Acute Myeloid Leukemia Cells.
Bi L; Yu Z; Wu J; Yu K; Hong G; Lu Z; Gao S
Tohoku J Exp Med; 2015 Nov; 237(3):163-72. PubMed ID: 26466521
[TBL] [Abstract][Full Text] [Related]
18. Stat3 regulates microtubules by antagonizing the depolymerization activity of stathmin.
Ng DC; Lin BH; Lim CP; Huang G; Zhang T; Poli V; Cao X
J Cell Biol; 2006 Jan; 172(2):245-57. PubMed ID: 16401721
[TBL] [Abstract][Full Text] [Related]
19. In vitro neutralization of autocrine IL‑10 affects Op18/stathmin signaling in non‑small cell lung cancer cells.
Zhao Y; Chen S; Shen F; Long D; Yu T; Wu M; Lin X
Oncol Rep; 2019 Jan; 41(1):501-511. PubMed ID: 30320402
[TBL] [Abstract][Full Text] [Related]
20. Phosphatase of regenerating liver-3 inhibits invasiveness and proliferation in non-small cell lung cancer by regulating the epithelial-mesenchymal transition.
Lin SY; Lee YX; Yu SL; Chang GC; Chen JJ
Oncotarget; 2016 Apr; 7(16):21799-811. PubMed ID: 26967563
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
